Clinical complications after a traumatic brain injury and its relation with brain biomarkers

被引:3
|
作者
Yuguero, Oriol [1 ,2 ]
Bernal, Maria [3 ]
Farre, Joan [3 ]
Martinez-Alonso, Montserrat [2 ,4 ]
Vena, Ana [1 ,2 ]
Purroy, Francisco [2 ,5 ]
机构
[1] Inst Biomed Res Dr Pifarre Fdn IRBLLEIDA, ERLab, Emergency Med Res Grp, Avda Rovira Roure 80, Lleida 25198, Spain
[2] Univ Lleida, Fac Med, Avda Rovira Roure 80, Lleida 25198, Spain
[3] Univ Hosp Arnau Vilanova, Clin Lab, Avda Rovira Roure 80, Lleida 25198, Spain
[4] Inst Biomed Res Dr Pifarre Fdn IRBLLEIDA, Syst Biol & Stat Methods Biomed Res Grp, Avda Rovira Roure 80, Lleida 25198, Spain
[5] Inst Biomed Res Dr Pifarre Fdn IRBLLEIDA, Clin Neurosci Grp, Avda Rovira Roure 80, Lleida 25198, Spain
关键词
NEURON-SPECIFIC ENOLASE; MOLECULAR-MECHANISMS; S100B; EPIDEMIOLOGY; OUTCOMES; PROTEIN; CARE;
D O I
10.1038/s41598-023-47267-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We aimed to find out which are the most frequent complications for patients who suffer a traumatic brain injury (TBI) and its relation with brain biomarker levels. We conducted a hospital cohort study with patients who attended the Hospital Emergency Department between 1 June 2018 and 31 December 2020. Different variables were collected such as biomarkers levels after 6 h and 12 h of TBI (S100, NSE, UCHL1 and GFAP), clinical and sociodemographic variables, complementary tests, and complications 48 h and 7 days after TBI. Qualitative variables were analysed with Pearson's chi-square test, and quantitative variables with the Mann-Whitney U test. A multivariate logistic regression model for the existence of complications one week after discharge was performed to assess the discriminatory capacity of the clinical variables. A total of 51 controls and 540 patients were included in this study. In the TBI group, the mean age was 83 years, and 53.9% of the patients were male. Complications at seven days were associated with the severity of TBI (p < 0.05) and the number of platelets (p = 0.016). All biomarkers except GFAP showed significant differences in their distribution of values according to gender, with significantly higher values of the three biomarkers for women with respect to men. Patients with complications presented significantly higher S100 values (p < 0.05). The patient's baseline status, the severity of the TBI and the S100 levels can be very important elements in determining whether a patient may develop complications in the few hours after TBI.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Clinical complications after a traumatic brain injury and its relation with brain biomarkers
    Oriol Yuguero
    Maria Bernal
    Joan Farré
    Montserrat Martinez-Alonso
    Ana Vena
    Francisco Purroy
    Scientific Reports, 13
  • [2] Extracranial complications after traumatic brain injury: targeting the brain and the body
    Robba, Chiara
    Bonatti, Giulia
    Pelosi, Paolo
    Citerio, Giuseppe
    CURRENT OPINION IN CRITICAL CARE, 2020, 26 (02) : 137 - 146
  • [3] The utility of biomarkers in traumatic brain injury clinical management
    Ana Rodríguez-Rodríguez
    Juan José Egea-Guerrero
    Critical Care, 20
  • [4] Biomarkers in the Clinical Diagnosis and Management of Traumatic Brain Injury
    Georgene W. Hergenroeder
    John B. Redell
    Anthony N. Moore
    Pramod K. Dash
    Molecular Diagnosis & Therapy, 2008, 12 : 345 - 358
  • [5] Clinical applications of biomarkers in pediatric traumatic brain injury
    Simon J. I. Sandler
    Anthony A. Figaji
    P. David Adelson
    Child's Nervous System, 2010, 26 : 205 - 213
  • [6] The utility of biomarkers in traumatic brain injury clinical management
    Peter Thelin, Eric
    Jeppsson, Emma
    Bellander, Bo-Michael
    Nelson, David W.
    CRITICAL CARE, 2016, 20
  • [7] Clinical applications of biomarkers in pediatric traumatic brain injury
    Sandler, Simon J. I.
    Figaji, Anthony A.
    Adelson, P. David
    CHILDS NERVOUS SYSTEM, 2010, 26 (02) : 205 - 213
  • [8] The utility of biomarkers in traumatic brain injury clinical management
    Rodriguez-Rodriguez, Ana
    Jose Egea-Guerrero, Juan
    CRITICAL CARE, 2016, 20
  • [9] Biomarkers in the Clinical Diagnosis and Management of Traumatic Brain Injury
    Hergenroeder, Georgene W.
    Redell, John B.
    Moore, Anthony N.
    Dash, Pramod K.
    MOLECULAR DIAGNOSIS & THERAPY, 2008, 12 (06) : 345 - 358
  • [10] Biomarkers in Traumatic Brain Injury
    Richa Sharma
    Daniel T. Laskowitz
    Current Neurology and Neuroscience Reports, 2012, 12 : 560 - 569